FDA and NIH Collaborate on Unified Approach to Adverse Event Reporting

Summary

The Food and Drug Administration (FDA) and the National Institutes of Health (NIH) have signed a Memorandum of Understanding (MOU) to develop a web-based system for reporting adverse events, aiming to improve the efficiency and accuracy of the process.